Abstract
ATPase, class 1, type 8 A, member 2 (ATP8A2) is a P4-ATPase with a critical role in phospholipid translocation across the plasma membrane. Pathogenic variants in ATP8A2 are known to cause cerebellar ataxia, impaired intellectual development, and disequilibrium syndrome 4 (CAMRQ4) which is often associated with encephalopathy, global developmental delay, and severe motor deficits. Here, we present a family with two siblings born from a consanguineous, first-cousin union from Sudan presenting with global developmental delay, intellectual disability, spasticity, ataxia, nystagmus, and thin corpus callosum. Whole exome sequencing revealed a homozygous missense variant in the nucleotide binding domain of ATP8A2 (p.Leu538Pro) that results in near complete loss of protein expression. This is in line with other missense variants in the same domain leading to protein misfolding and loss of ATPase function. In addition, by performing diffusion-weighted imaging, we identified bilateral hyperintensities in the posterior limbs of the internal capsule suggesting possible microstructural changes in axon tracts that had not been appreciated before and could contribute to the sensorimotor deficits in these individuals.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Biallelic mutations in ATPase, class 1, type 8 A, member 2 (ATP8A2) (MIM:605870) cause cerebellar ataxia, impaired intellectual development, and disequilibrium syndrome 4 (CAMRQ4, MIM:615268). The classic presentation of CAMRQ4 is characterized by intellectual disability, ataxia, dysarthria, and occasionally quadrupedal gait [1]. However, the spectrum of phenotypes caused by ATP8A2 loss of function is variable due to the broad expression pattern of this gene in the brain and eyes.
ATP8A2 encodes a P4-ATPase that forms a complex with CDC50A to translocate phospholipids phosphatidylserine (PS) and phosphatidylethanolamine (PE) from the outer (exoplasmic) layer of the membrane to the inner cytoplasmic layer, thus maintaining asymmetry in the composition of the lipid bilayer [2,3,4]. Phospholipid asymmetry confers different structural and functional properties to the outer and inner sides of the plasma membrane [5]. For example, PS in the exoplasmic layer of the cell membrane triggers phagocytosis of apoptotic cells controlling cell survival [6, 7]. In addition to apoptosis, exoplasmic PS is also known to play a vital role in physiological processes including blood coagulation [8] and myotube formation [9].
ATP8A2 is expressed in many brain regions, with highest expression observed in the cerebellum [10] and the hippocampus [11]. The expression pattern strongly correlates with structural brain malformations observed in patients with pathogenic ATP8A2 variants including atrophy of the cerebral cortex, corpus callosum, and cerebellum [10, 12]. However, not all patients with pathogenic ATP8A2 variants present with overt brain abnormalities [13]. In fact, one study reported normal magnetic resonance imaging (MRI) of the brain in 50% of patients [14], while another noted normal brain MRI in 3/3 patients [1]. ATP8A2 is also strongly expressed in the retina [3, 11], and some patients have presented with impaired visual acuity, nystagmus, ophthalmoplegia, and bilateral optic disk atrophy [1, 12].
Rodent models of Atp8a2 loss of function have recapitulated many aspects of CAMRQ4 that are observed in humans and uncovered underlying processes that may contribute to disease phenotypes. Wabbler-lethal (wl) mutant mice, which harbor a spontaneous mutation in Atp8a2, exhibit reduced survival, reduced body weight, abnormal gait characterized by dragging of the hind feet, hind limb clasping indicative of an underlying neurological deficit, and distal axonal degeneration [15], the latter of which corroborated an earlier electron microscopy study of the wl mouse nervous system [16]. Further evidence for the role of ATP8A2 in axons was uncovered in rats where overexpression of ATP8A2 was found to increase axon length in hippocampal neurons [17]. The visual system was also strongly affected in wl mice where photoreceptor proteins were found to be correctly localized, but a reduction in the number of photoreceptors in the retina as well as the length of the outer segment layer was noted [18]. Degeneration of the optic nerve was also observed in wl mice [19].
Here, we present the case of two siblings born from a consanguineous union from Sudan with a novel homozygous missense variant in ATP8A2 identified through whole exome sequencing (WES). Both siblings exhibited classic CAMRQ4 symptoms including dysarthria, spasticity, and delayed motor milestones. Additionally, novel brain MRI findings of bilateral hyperintensities of the posterior limbs of the internal capsule, as well as thinned corpora callosa were observed in each case. As such, this case study further expands our knowledge of the phenotypic spectrum caused by biallelic mutations in ATP8A2.
Methods
Subjects
Ethics approval was received from the Ethical Committee of Medical Campus, University of Khartoum, Sudan, the Ethical Committee of the National University, Sudan (approval number NU-RECG200), and the Institutional Review Board at Rutgers University. Each patient and their parents were fully informed of the purpose and procedures of this study and written consent was obtained before participation. Detailed personal data, age of onset, pregnancy, and delivery history as well as family history of similar condition or any other genetic disorders with 3-generation pedigree construction were completed. Physical examination, full neurological assessment and anthropometric measurements were performed in the initial and follow-up visits. Ophthalmological examination and MRI of the brain were also performed.
Whole exome sequencing and variant analysis
WES was performed on DNA obtained from the siblings and their unaffected parents at the Broad Institute Genomic Services (Broad Institute, Cambridge, MA). Reads were aligned to hg38 with BowTie2 [20], and variants were called with SAMtools [21] and GATK [22]. Variant call format (VCF) files were then annotated with ANNOVAR [23] and stored in a custom SQL database. Homozygous variants likely to affect gene function (nonsense, missense, frameshift deletion/insertion, non-frameshift deletion/insertion, start loss, stop loss) were filtered for allele frequencies less than 1% in the Genome Aggregation Database African population and whole population [24] and the Greater Middle Eastern Variome Northeast African population and whole population [25]. SIFT [26], PolyPhen2 [27], CADD [28], and REVEL [29] were used to assess the pathogenicity of missense variants. After identification of the candidate ATP8A2 variant, FoldX5 [30] was used to predict protein stability through a ∆∆G value representing the Gibbs Free Energy Change (∆G) of the variant ATP8A2 protein minus the ∆G of the wild type (WT) protein. Healthy siblings did not undergo genetic testing, but shared inheritance and heterozygosity in each parent were confirmed in the variant filtering process.
Plasmid construct design
The human ATP8A2 construct was previously cloned into a pcDNA3.1 plasmid engineered to contain a C-terminal 1D4 tag [31, 32]. The p.Leu538Pro mutant construct was developed using site directed mutagenesis with overlapping primers designed to incorporate the missense mutation into the WT ATP8A2 construct using Phusion polymerase. Mutations were verified by Sanger sequencing and re-ligated into the WT plasmid using the KPN1 and Xba1 restriction enzymes.
Cell culture and protein expression
HEK293T cells were cultured in DMEM (Sigma-Aldrich) supplemented with 8% bovine growth serum (Thermo Scientific), 100 IU/ml penicillin, 100 µg/ml streptomycin, and 2 mM l-glutamine. The cells grown on 10 cm plates to ~ 50% confluency were co-transfected with 5 µg each of the ATP8A2 plasmid and CDC50A plasmids and 30 µg of polyethylenimine (PEI) per plate. The cells were harvested after 24 h and pelleted at 2000 rcf (Sorval LegendRT). The cells were resuspended in lysis buffer (150mM NaCl, 50mM HEPES/NaOH pH 7.5, 5mM MgCl2, 20 mM CHAPS, 1x Protease Arrest, 1mM dithiothreitol (DTT), 0.5 mg/mL DOPC) with stirring at 4 °C. After 30 min, the detergent insoluble membrane fraction was removed by centrifugation at 40,000 rcf for 12 min. Protein expression was measured by western blotting analysis labeled with the Rho1D4 antibody and normalized to a tubulin loading control as previously described [31].
Results
Case reports
Here, we present 2 siblings born to healthy, consanguineous first-cousin parents from Sudan (Fig. 1A). In addition, there was one spontaneous termination of pregnancy for which information was not available. The proband (P1) is a male who presented with ataxia and severe global developmental delay. The pregnancy and delivery history were uneventful. At 3 years of age, he was hypotonic and areflexic, and lacked head control. He was unable to crawl or speak. By 8 years of age, he had dysarthria, nystagmus, and dysmetria, with greater interest in his surroundings, and ambulation with unilateral support. Hearing and vision remained intact. Further examination revealed microcephaly, spasticity, and hyperreflexia of both upper and lower limbs, in addition to feet deformity. Brain MRI showed a mildly thinned corpus callosum and mildly dilated lateral ventricles (Fig. 1B-C), but the cerebellum was intact. The diffusion-weighted imaging (DWI) sequences showed bilateral symmetric hyperintensities in the posterior limbs of the internal capsules (Fig. 1D). His younger sister (P2) presented also with delayed milestones. At 4 years old, she had dysarthria, and she could walk with support. Microcephaly, nystagmus, and spasticity of upper and lower limbs were present, but there was no ataxia. MRI of the brain showed a thinned corpus callosum and bilateral symmetric DWI hyperintense signals in the posterior limbs of the internal capsules (Fig. 1E).
Whole exome sequencing identified a candidate ATP8A2 variant
After WES, bioinformatic processing, and variant filtering, two homozygous variants were shared between the siblings with confirmed inheritance from each parent. One missense variant was detected in DNAH2 (MIM:603,333; NM_020877.5:c.6086 A > C; NP_065928.2:p.Asp2029Ala) and was predicted by SIFT, PolyPhen2, and CADD to be damaging (SIFT: 0; PolyPhen2: 1; CADD: 27.5; REVEL: 0.775). However, biallelic mutations in DNAH2 cause spermatogenic failure and are not known to be associated with central nervous system pathology [33, 34]. As such, this variant was ruled out as a possible candidate for the neurological presentation of the siblings.
Only a missense variant in ATP8A2 (NM_016529.6:c.1613T > C; NP_057613.4:p.Leu538Pro), which is highly expressed throughout the brain [10, 11] and is a known cause of CAMRQ4, remained. This variant was strongly predicted to be deleterious by SIFT, PolyPhen2, CADD, and REVEL (SIFT: 0.001; PolyPhen2 HumDiv: 0.999; PolyPhen2 HumVar: 0.987; CADD: 28.4; REVEL: 0.781) and has never been reported in the literature or in ClinVar. This variant occurred in the cytoplasmic nucleotide binding (N) catalytic domain (Fig. 2A), specifically within an alpha helical secondary structure (Fig. 2B). Interestingly, it occurred at an amino acid residue that is highly conserved among other species but not most other P4-ATPases where amino acids with hydrophobic side chains are present (Fig. 2C). Using FoldX5 [30], which has been used in a previous study to predict the effect of point mutations on the overall stability of ATP8A2 [35], we found that the proline substitution at this position likely causes a break in the helical segment leading to severe protein misfolding. As such, FoldX5 predicted a ∆∆G value of + 4.25 kcal/mol, representing a destabilizing effect of this amino acid substitution. Our in vitro studies supported this prediction, as the p.Leu538Pro variant resulted in a severe reduction in protein expression (Fig. 2D-E), a finding consistent with numerous other ATP8A2-disease-causing variants [31, 32, 35]. Based on our findings, the American College of Medical Genomics (ACMG) guidelines for variant pathogenicity interpretation indicate that this variant is pathogenic based on one strong, two moderate, and two supporting criteria (Supplementary Table 1) [36].
Discussion
ATP8A2 mutations have been identified as the underlying cause of CAMRQ4 syndrome which is characterized by encephalopathy, intellectual disability, severe hypotonia, psychomotor delay, chorea, and optic atrophy [1, 10,11,12,13,14, 32, 37]. Additionally, individuals with ATP8A2 mutations may exhibit other neurological manifestations such as tremors, seizures, and/or abnormal brain imaging, especially cerebellar atrophy [32]. The patients described in this study harbor a novel, homozygous missense variant (p.Leu538Pro) at a highly conserved amino acid in ATP8A2 that results in protein degradation, likely due to severe misfolding. Missense variation in the cytoplasmic catalytic domains, primarily the nucleotide binding (N) and phosphorylation (P) domains, has become an increasingly common mechanism of ATP8A2-related disease [10, 12, 14, 31, 32, 35, 38]. As such, we classify this variant as pathogenic based on ACMG criteria.
The cytoplasmic N, P, and actuator (A) catalytic domains are well conserved in P-type ATPases, with the N domain acting as a kinase, the A domain acting as a phosphatase, and the P domain containing an aspartic acid residue (Asp428) that the N and A domains act on [39]. Upon Asp428 phosphorylation, PS and PE are flipped from the exoplasmic leaflet to the cytoplasmic leaflet of the plasma membrane [40]. Multiple studies have focused significant attention on missense variants in these catalytic domains and their effects on protein expression, localization, and ATPase activity. Most reported missense variants are in the N and P domains (Fig. 2B, Table 1) where they disrupt ATPase activity (P: p.Lys429Met, p.Met438Val; N: p.Gly585Val) and often also cause loss of expression in addition to reduced/absent activity (P: p.Lys429Asn, p.Ala772Pro, p.Tyr639Cys, p.Trp702Arg, p.Asp825His; N: p.Ala544Pro, p.Gly447Arg, p.Gly447Ala, p.Gly447Glu, p.Arg588Trp, p.Arg625Trp) [31, 32, 35, 38, 41]. p.Lys429Asn and p.Lys429Met occur directly adjacent to the D428 active site [31, 39]. A variant in the A domain (p.Ile215Leu), however, did not disrupt ATP8A2 stability or activity [32]. The p.Leu538Pro variant identified in the present cases results in near total loss of ATP8A2 expression, likely due to the proline substitution breaking the alpha helical structure where this residue resides. Based on our findings and the findings of others, it is evident that the N and P domains are mutational hotspots, and missense variants in these domains often profoundly impact ATP8A2 stability and function. One recent study by Morgansen et al. simulated ATPase activity in 130 ATP8A2 missense variants in the M1-M4 transmembrane segments [42], which could have applicability for prioritizing missense variants within the catalytic domains for experimental validation in the future, as many variants of uncertain significance (VUS) remain unsolved.
Since many missense variants in the catalytic domains have been shown to result in loss of function, genotype-phenotype correlations in ATP8A2-related disease are complex. For example, of all of the missense variations in the cytoplasmic catalytic domains, normal brain MRI was only observed in a patient with the p.Trp702Arg variant while all others showed some degree of abnormality, including the two siblings reported in this case study [32]; Heidari et al., [12, 14, 38, 41]. This was in contrast to several reported frameshift and nonsense variants where brain MRI was normal in some or all patients (p.Arg581*, p.Asn596fs; p.Pro492_Ala554del; p.Arg588fs) [1, 14, 43, 44), furthering highlighting the severity of ATP8A2-related disease that can stem from missense variants in the catalytic domains. There is also drastic variability in the brain manifestations that are reported across patients with ATP8A2 variants, which correlates strongly to the broad expression pattern of ATP8A2 in many brain regions [10, 11]. Interestingly, in the patients reported in this study, DWI revealed bilateral symmetric internal capsule hyperintensities that have not been previously reported in any patient with ATP8A2 variants, which could explain documented sensorimotor deficits. These findings indicate restricted capsular water diffusion which can be caused by ischemia, inflammation, increased cell turnover, but most likely represent ongoing microstructural axonal dysfunction. Since DWI results were not listed in previous reports, the prevalence of this phenotype is unknown and diffusion imaging may be indicated in the analysis of future cases.
Compared to other cases in the literature, our patients exhibited many features shared by most other patients including developmental delay, intellectual disability, and dysarthria [37]. However, they presented with a milder clinical manifestation comparable to two families reported by Guissart et al. harboring missense variants in the N domain near the p.Leu538Pro variant. One Turkish family with two siblings born from first-degree consanguineous parents carried the p.Gly585Val variant in homozygosity and presented with mild cerebellar ataxia. They were ambulant with ataxic gait. Mild cerebellar atrophy was observed on their MRI. They did not have encephalopathy, but had dysmetria, dysarthria, nystagmus, optic atrophy, tremors, and head titubation. The other family had one girl with the p.Arg588Trp variant in homozygosity and presented with transient encephalopathy, developmental delay, hypotonia, nystagmus, dysmetria, and dysarthria, along with hearing loss. However, she was able to stand and walk with aid [32]. Our patients presented with many of the same features, though neither one had optic atrophy or cerebellar atrophy, and P2 did not manifest ataxia.
The findings of this study and review of reported variation in ATP8A2 highlights how missense variation in the catalytic domains of this gene should not be overlooked in next generation sequencing studies. In fact, we believe that the combined knowledge of pathogenic phenotypes associated with catalytic domain missense changes could warrant reassessment of pathogenicity classification of many VUSs. Overall, the cases reported in this study introduce novel brain MRI findings into the clinical spectrum of ATP8A2-related disease, and further highlight the role of ATP8A2 missense variants destabilizing the protein as a common mechanism.
Data availability
Data reported in this study will be made available upon request from the corresponding author.
References
Alsahli S, Alrifai MT, Tala A, Mutairi S, F. A., Alfadhel M (2018) Further delineation of the clinical phenotype of cerebellar Ataxia, Mental Retardation, and disequilibrium syndrome type 4. J Cent Nerv Syst Dis 10:1179573518759682. https://doi.org/10.1177/1179573518759682
Coleman JA, Molday RS (2011) Critical role of the beta-subunit CDC50A in the stable expression, assembly, subcellular localization, and lipid transport activity of the P4-ATPase ATP8A2. J Biol Chem 286(19):17205–17216. https://doi.org/10.1074/jbc.M111.229419
Tadini-Buoninsegni F, Mikkelsen SA, Mogensen LS, Molday RS, Andersen JP (2019) Phosphatidylserine flipping by the P4-ATPase ATP8A2 is electrogenic. Proc Natl Acad Sci U S A 116(33):16332–16337. https://doi.org/10.1073/pnas.1910211116
Vestergaard AL, Coleman JA, Lemmin T, Mikkelsen SA, Molday LL, Vilsen B, Molday RS, Peraro D, M., Andersen JP (2014) Critical roles of isoleucine-364 and adjacent residues in a hydrophobic gate control of phospholipid transport by the mammalian P4-ATPase ATP8A2. Proc Natl Acad Sci U S A 111(14):E1334–1343. https://doi.org/10.1073/pnas.1321165111
Lorent JH, Levental KR, Ganesan L, Rivera-Longsworth G, Sezgin E, Doktorova M, Lyman E, Levental I (2020) Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape. Nat Chem Biol 16(6):644–652. https://doi.org/10.1038/s41589-020-0529-6
Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148(7):2207–2216
Martin SJ, Finucane DM, Amarante-Mendes GP, O’Brien GA, Green DR (1996) Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem 271(46):28753–28756. https://doi.org/10.1074/jbc.271.46.28753
Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF (1982) Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122(2):429–436. https://doi.org/10.1111/j.1432-1033.1982.tb05898.x
van den Eijnde SM, van den Hoff MJ, Reutelingsperger CP, van Heerde WL, Henfling ME, Vermeij-Keers C, Schutte B, Borgers M, Ramaekers FC (2001) Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci 114(Pt 20):3631–3642. https://doi.org/10.1242/jcs.114.20.3631
Onat OE, Gulsuner S, Bilguvar K, Nazli Basak A, Topaloglu H, Tan M, Tan U, Gunel M, Ozcelik T (2013) Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion. Eur J Hum Genet 21(3):281–285. https://doi.org/10.1038/ejhg.2012.170
Cacciagli P, Haddad MR, Mignon-Ravix C, El-Waly B, Moncla A, Missirian C, Chabrol B, Villard L (2010) Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype. Eur J Hum Genet 18(12):1360–1363. https://doi.org/10.1038/ejhg.2010.126
Martín-Hernández E, Rodríguez-García ME, Camacho A, Matilla-Dueñas A, García-Silva MT, Quijada-Fraile P, Corral-Juan M, Tejada-Palacios P, de Las Heras RS, Arenas J, Martín MA, Martínez-Azorín F (2016) New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy. Neurogenetics 17(4):259–263. https://doi.org/10.1007/s10048-016-0496-y
Damásio J, Santos D, Morais S, Brás J, Guerreiro R, Sardoeira A, Cavaco S, Carrilho I, Barbot C, Barros J, Sequeiros J (2021) Congenital ataxia due to novel variant in ATP8A2. Clin Genet 100(1):79–83. https://doi.org/10.1111/cge.13954
McMillan HJ, Telegrafi A, Singleton A, Cho MT, Lelli D, Lynn FC, Griffin J, Asamoah A, Rinne T, Erasmus CE, Koolen DA, Haaxma CA, Keren B, Doummar D, Mignot C, Thompson I, Velsher L, Dehghani M, Mehrjardi V, Yoon MY, G (2018) Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy. Orphanet J Rare Dis 13(1):86. https://doi.org/10.1186/s13023-018-0825-3
Zhu X, Libby RT, de Vries WN, Smith RS, Wright DL, Bronson RT, Seburn KL, John SW (2012) Mutations in a P-type ATPase gene cause axonal degeneration. PLoS Genet 8(8):e1002853. https://doi.org/10.1371/journal.pgen.1002853
Luse SA, Chenard C, Finke EH (1967) The wabbler-lethal mouse. An electron microscopic study of the nervous system. Arch Neurol 17(2):153–161. https://doi.org/10.1001/archneur.1967.00470260043004
Xu Q, Yang GY, Liu N, Xu P, Chen YL, Zhou Z, Luo ZG, Ding X (2012) P4-ATPase ATP8A2 acts in synergy with CDC50A to enhance neurite outgrowth. FEBS Lett 586(13):1803–1812. https://doi.org/10.1016/j.febslet.2012.05.018
Coleman JA, Zhu X, Djajadi HR, Molday LL, Smith RS, Libby RT, John SW, Molday RS (2014) Phospholipid flippase ATP8A2 is required for normal visual and auditory function and photoreceptor and spiral ganglion cell survival. J Cell Sci 127(Pt 5):1138–1149. https://doi.org/10.1242/jcs.145052
Carroll EW, Curtis RL, Sullivan DA, Melvin JL (1992) Wallerian degeneration in the optic nerve of the wabbler-lethal (wl/wl) mouse. Brain Res Bull 29(3–4):411–418. https://doi.org/10.1016/0361-9230(92)90077-b
Langmead B, Salzberg SL (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9(4):357–359. https://doi.org/10.1038/nmeth.1923
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R (2009) The sequence Alignment/Map format and SAMtools. Bioinformatics 25(16):2078–2079. https://doi.org/10.1093/bioinformatics/btp352
Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, Jordan T, Shakir K, Roazen D, Thibault J, Banks E, Garimella KV, Altshuler D, Gabriel S, DePristo MA (2013) From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinf 43(1110). https://doi.org/10.1002/0471250953.bi1110s43
Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38(16):e164. https://doi.org/10.1093/nar/gkq603
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, MacArthur DG (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434–443. https://doi.org/10.1038/s41586-020-2308-7
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Alkuraya FS, Casanova JL, Gleeson JG (2016) Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat Genet 48(9):1071–1076. https://doi.org/10.1038/ng.3592
Ng PC, Henikoff S (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812–3814. https://doi.org/10.1093/nar/gkg509
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. Chap. 7, Unit7.20 https://doi.org/10.1002/0471142905.hg0720s76
Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47(D1):D886–d894. https://doi.org/10.1093/nar/gky1016
Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, O’Donnell-Luria A, Harrison SM, Tavtigian SV, Greenblatt MS, Biesecker LG, Radivojac P, Brenner SE (2022) Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am J Hum Genet 109(12):2163–2177. https://doi.org/10.1016/j.ajhg.2022.10.013
Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L (2005) The FoldX web server: an online force field. Nucleic Acids Res 33:W382–388. Web Server issuehttps://doi.org/10.1093/nar/gki387
Choi H, Andersen JP, Molday RS (2019) Expression and functional characterization of missense mutations in ATP8A2 linked to severe neurological disorders. Hum Mutat 40(12):2353–2364. https://doi.org/10.1002/humu.23889
Guissart C, Harrison AN, Benkirane M, Oncel I, Arslan EA, Chassevent AK, Baraῆano K, Larrieu L, Iascone M, Tenconi R, Claustres M, Eroglu-Ertugrul N, Calvas P, Topaloglu H, Molday RS, Koenig M (2020) ATP8A2-related disorders as recessive cerebellar ataxia. J Neurol 267(1):203–213. https://doi.org/10.1007/s00415-019-09579-4
Li Y, Sha Y, Wang X, Ding L, Liu W, Ji Z, Mei L, Huang X, Lin S, Kong S, Lu J, Qin W, Zhang X, Zhuang J, Tang Y, Lu Z (2019) DNAH2 is a novel candidate gene associated with multiple morphological abnormalities of the sperm flagella. Clin Genet 95(5):590–600. https://doi.org/10.1111/cge.13525
Li Y, Wang Y, Wen Y, Zhang T, Wang X, Jiang C, Zheng R, Zhou F, Chen D, Yang Y, Shen Y (2021) Whole-exome sequencing of a cohort of infertile men reveals novel causative genes in teratozoospermia that are chiefly related to sperm head defects. Hum Reprod 37(1):152–177. https://doi.org/10.1093/humrep/deab229
Matsell E, Andersen JP, Molday RS (2024) Functional and In-silico analysis of ATP8A2 and other P4-ATPase variants associated with human genetic diseases. Dis Model Mech. https://doi.org/10.1242/dmm.050546
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424. https://doi.org/10.1038/gim.2015.30
Narishige Y, Yaoita H, Shibuya M, Ikeda M, Kodama K, Kawashima A, Okubo Y, Endo W, Inui T, Togashi N, Tanaka S, Kobayashi Y, Onuma A, Takayama J, Tamiya G, Kikuchi A, Kure S, Haginoya K (2022) Two siblings with cerebellar Ataxia, Mental Retardation, and disequilibrium syndrome 4 and a Novel variant of ATP8A2. Tohoku J Exp Med 256(4):321–326. https://doi.org/10.1620/tjem.2022.J010
Heidari E, Harrison AN, Jafarinia E, Tavasoli AR, Almadani N, Molday RS, Garshasbi M (2021) Novel variants in critical domains of ATP8A2 and expansion of clinical spectrum. Hum Mutat 42(5):491–497. https://doi.org/10.1002/humu.24180
Palmgren MG, Nissen P (2011) P-type ATPases. Annu Rev Biophys 40:243–266. https://doi.org/10.1146/annurev.biophys.093008.131331
López-Marqués RL, Gourdon P, Günther Pomorski T, Palmgren M (2020) The transport mechanism of P4 ATPase lipid flippases. Biochem J 477(19):3769–3790. https://doi.org/10.1042/bcj20200249
Mohamadian M, Ghandil P, Naseri M, Bahrami A, Momen AA (2020) A novel homozygous variant in an Iranian pedigree with cerebellar ataxia, mental retardation, and dysequilibrium syndrome type 4. J Clin Lab Anal 34(11):e23484. https://doi.org/10.1002/jcla.23484
Mogensen LS, Mikkelsen SA, Tadini-Buoninsegni F, Holm R, Matsell E, Vilsen B, Molday RS, Andersen JP (2024) On the track of the lipid transport pathway of the phospholipid flippase ATP8A2 - mutation analysis of residues of the transmembrane segments M1, M2, M3 and M4. Biochim Biophys Acta Mol Cell Res 1871(1):119570. https://doi.org/10.1016/j.bbamcr.2023.119570
Alves Corazza L, Lopes Braga V, Yoshinaga Tonholo Silva T, Moura Rezende Filho F, Ferraz Sallum JM, Povoas Barsottini G, O., Pedroso JL (2023) ATP8A2-Related disorder: beyond cerebellar Ataxia. Mov Disord Clin Pract 10(8):1215–1216. https://doi.org/10.1002/mdc3.13820
Quintas SM, dos Santos O, Levy TP, A (2017) New syndrome associated with ATP8A2 gene mutations: Encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy whole-exome sequencing role in the diagnosis of new diseases. Eur J Pediatr Neurol 21:e65. https://doi.org/10.1016/j.ejpn.2017.04.935
Acknowledgements
We thank the family for their participation in our study.
Funding
The research was supported by funding from the National Institutes of Health (grant #R01NS109149) and the Robert Wood Johnson Foundation (grant #74260) to M.C.M. S.S. was supported by a fellowship from the Egyptian Ministry of Higher Education.
Author information
Authors and Affiliations
Contributions
KPF, SS, and MCM designed the study; AY, AAAH, LEOE, and MCM enrolled the research participants; MK, RA, FA, and AY collected the samples and relevant data; MAS, AY, VB, AAAH, INM, and MAE collected and reviewed the clinical information; KPF, SS, and MCM analyzed the sequencing data; EM and RSM performed and analyzed the protein expression experiments; KPF, SS, EM, RSM, and MCM wrote the manuscript; all authors reviewed the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Flannery, K.P., Safwat, S., Matsell, E. et al. A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes. Neurogenetics (2024). https://doi.org/10.1007/s10048-024-00773-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10048-024-00773-9